Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on O H Bond Insertion. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101412738A details a novel iron-catalyzed asymmetric O-H insertion. This technology offers cost-effective, high-enantioselectivity routes for API intermediates.
Patent CN115974758A reveals safe iridium-catalyzed synthesis avoiding diazo compounds. Delivers cost reduction in pharmaceutical intermediate manufacturing with superior scalability.